SCHEMBL29601254

SCHEMBL29601254

c1ccc(SSC2CCCCCC2)nc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 1/20 0.55
EHMT1 Q9H9B1 1/20 0.55
APOBEC3G Q9HC16 1/20 0.55
TXN P10599 4/20 0.47
ALDH1A1 P00352 5/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CYP1A2 P05177 1/20 0.40
GRM5 P41594 1/20 0.40
KDM4E B2RXH2 2/20 0.39
GAA P10253 1/20 0.39
CRBN Q96SW2 2/20 0.38
DDB1 Q16531 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30195276 1.00 EHMT2 (0.55) EHMT2EHMT1APOBEC3GTXNALDH1A1
SCHEMBL16710894 1.00 EHMT2 (0.55) EHMT2EHMT1APOBEC3GTXNALDH1A1
SCHEMBL22882906 1.00 EHMT2 (0.55) EHMT2EHMT1APOBEC3GTXNALDH1A1
SCHEMBL30448686 0.98 EHMT2 (0.57) EHMT2EHMT1APOBEC3GTXNALDH1A1
SCHEMBL22882815 0.98 EHMT2 (0.57) EHMT2EHMT1APOBEC3GTXNALDH1A1
SCHEMBL22893342 0.83 EHMT2 (0.52) EHMT2EHMT1APOBEC3GTXNALDH1A1
SCHEMBL22882827 0.83 EHMT2 (0.52) EHMT2EHMT1APOBEC3GTXNALDH1A1
SCHEMBL22882826 0.83 EHMT2 (0.52) EHMT2EHMT1APOBEC3GTXNALDH1A1
SCHEMBL12949631 0.81 EHMT2 (0.48) EHMT2EHMT1APOBEC3GALDH1A1KMT2A
SCHEMBL15271760 0.81 EHMT2 (0.48) EHMT2EHMT1APOBEC3GALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3997093-A1 PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS Cybrexa 2, Inc. (US) 2022-05-18 EP disclosed